A Phase I Open-label Study for Subjects With Advanced Malignancies

Clinical trial NCT04136834 · UNKNOWN

Trial details

NCT number: NCT04136834
Sponsor: Athenex, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancies

Start date: 2021-04-21
Primary completion: 2022-12-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.